Live Experiences in People with Myasthenia Gravis: A Qualitative Study
DOI:
https://doi.org/10.60099/jtnmc.v39i04.269586Keywords:
live experiences, myasthenia gravis , qualitative researchAbstract
Introduction Myasthenia gravis (MG) is an autoimmune disorder characterized by severe muscle weakness, which can lead to acute respiratory failure. The unpredictable symptoms of MG affect both physical and mental health, affecting daily activities, work, and social interactions. This can result in negative self-perception, ultimately diminishing patients’ quality of life. A comprehensive understanding of the condition is crucial for improving patient care.
Objective To explore the live experiences of people with MG regarding their perception of the disease, lifestyle changes, self-management, and perception of the remaining life
Design A descriptive qualitative design
Methods The informants included 15 people aged 18 and older who had been diagnosed with MG and had received treatment for at least six months at a super-tertiary hospital in Bangkok. Purposive sampling was used according to the inclusion criteria. In-depth interviews were conducted using semi-structured interview guides that focused on their experiences, perceptions of the disease, lifestyle changes, self-management, and perceptions of the remaining life. Data were analyzed using content analysis based on Colaizzi’s framework. The trustworthiness of the research was assessed through credibility, confirmability, and transferability.
Findings The informants, aged 27 to 85, had been diagnosed with MG for periods ranging from 1 to 40 years. Most were treated with medication, while some also received intravenous immunoglobulin. Findings were categorized into three main themes: 1) Life Will Never Be the Same, including living with uncertainty, living with limitations, and enduring suffering; 2) Self-Management, including strict adherence to medication and appointments, awareness and self-monitoring, avoidance of risk behaviors, keeping physical fitness, and acceptance of living with the illness; and 3) Perception of Remaining Life, including expecting to live still, expecting for treatment outcomes, expecting nothing, and expecting for support from others.
Recommendation Findings from this study highlight how people with MG navigate life and manage their chronic conditions. Healthcare teams can use this information to develop tailored care plans. Additionally, future research can use this information to develop strategies to improve patient care and their quality of life.
Downloads
References
Kulkantrakorn K. Standard treatment in myasthenia gravis. Thai Journal of Neurology. 2017;33(3):1-8. Available from: http://neurothai.org/images/journal/2017/vol33_no3/vol33_no3_2560.pdf (in Thai)
Estephan EP, Baima JPS, Zambon AA. Myasthenia gravis in clinical practice. Arquivos de neuro-psiquiatria. 2022;80(5 Suppl 1):257-265. http://doi.org/10.1590/0004-282X-ANP-2022-S105 PMID: 35976295
Dresser L, Wlodarski R, Rezania K, Soliven B. Myasthenia gravis: epidemiology, pathophysiology and clinical manifestations. Journal of clinical medicine. 2021;10(11):2235. https://doi.org/10.3390/jcm10112235 PMID: 34064035
Salari N, Fatahi B, Bartina Y, Kazeminia M, Fatahian R, Mohammadi P, et al. Global prevalence of myasthenia gravis and the effectiveness of common drugs in its treatment: a systematic review and meta-analysis. Journal of Translational Medicine. 2021;19(1):1-23. https://doi.org/10.1186/s12967-021-03185-7
Keer-Keer T. Living with a chronic illness. Kai Tiaki Nursing New Zealand. 2018;24(7): 26-28. Available from: https://www.proquest.com/scholarly-journals/living-with-chronicillness/docview/2091679004se-2
Chen J, Tian DC, Zhang C, Li Z, Zhai Y, Xiu Y, et al. Incidence, mortality, and economic burden of myasthenia gravis in China: a nationwide population-based study. The Lancet Regional Health West Pacific. 2020; 27(5):100063. https://doi.org/10.1016/j.lanwpc.2020.100063 PMID: 34327399
Bubuioc AM, Kudebayeva A, Turuspekova S, Lisnic V, Leone MA. The epidemiology of myasthenia gravis. Journal of medicine and life. 2021;14(1):7-16. https://doi.org/10.25122/jml-2020-0145 PMID: 33767779
Saengow U, Aksornthong R, Laohaprapanon A. Synthesis of healthcare systems for rare diseases in Thailand. Bangkok: Research institute for health sciences Walailak University; 2018 [cited 2022 Jan 2]. Available from: https://kb.hsri.or.th/dspace/handle/11228/4916?locale-attribute=th (in Thai)
Jeong A, Min JH, Kang YK, Kim J, Choi M, Seok JM, et al. Factors associated with quality of life of people with myasthenia gravis. Plos One. 2018;13(11): e0206754. https://doi.org/10.1371/journal.pone.0206754 PMID: 30408057
Szczudlik P, Sobieszczuk E, Szyluk B, Lipowska M, Kubiszewska J, Kostera-Pruszczyk A. Determinants of quality of life in myasthenia gravis patients. Frontiers in Neurology. 2020;11:553626. https://doi.org/10.3389/fneur.2020.553626 PMID: 33071942
Saisut T, Tiamkao S, Thitima K. Quality of life in myasthenia gravis patients at Srinagarind Hospital. North Eastern Thai Journal of Neuroscience. 2008;3(4):23-38. Available from: http://110-170-189-210.static.asianet.co.th/articles/1181 (in Thai)
Jackson K, Parthan A, Lauher-Charest M, Broderick L, Law N, Barnett C. Understanding the symptom burden and impact of myasthenia gravis from the patient’s perspective: a qualitative study. Neurol Ther. 2023; 12(1):107-128. https://doi.org/10.1007/s40120-022-00408-x PMID: 36322146
Hoffmann S, Ramm J, Grittner U, Kohler S, Siedler J, Meisel A. Fatigue in myasthenia gravis: risk factors and impact on quality of life. Brain and Behavior. 2016; 6(10):e00538. https://doi.org/10.1002/brb3.538 PMID: 27781147
Van der Beek KM, Bos I, Middel B, Wynia K. Experienced stigmatization reduced quality of life of patients with a neuromuscular disease: a cross-sectional study. Clinical Rehabilitation. 2013;27(11):1029-38. https://doi.org/10.1177/0269215513487234 PMID: 23818411
Stojanov A, Milosevic V, Dordevic G, Stojanov J. Quality of life of myasthenia gravis patients in regard to epidemiological and clinical characteristics of the disease. The Neurologist. 2019;24(4):115-120. https://doi.org/10.1097/nrl.0000000000000238 PMID: 31246720
Law N, Davio K, Blunck M, Lobban D, Seddik K. The lived experience of myasthenia gravis: a patient-led analysis. Neurol Ther. 2021;10(2):1103-1125. https://doi.org/10.1007/s40120-021-00285-w PMID: 34687427
Dewilde S, Phillips G, Paci S, De Ruyck F, Tollenaar NH, Janssen MF. The burden patients with myasthenia gravis experience in terms of breathing, fatigue, sleep, mental health, discomfort and usual activities in comparison to the general population. Advances in Therapy. 2024; 41(1):271-291. https://doi.org/10.1007/s12325-023-02704-w PMID: 37921955
Doyle L, McCabe C, Keogh B, Brady A, McCann M. An overview of the qualitative descriptive design within nursing research. Journal of Research in Nursing. 2020;25(5):443-455. https://doi.org/10.1177/1744987119880234 PMID: 34394658
Wojnar DM, Swanson KM. Phenomenology: an exploration. Journal of Holistic Nursing. 2007;25(3): 172-80; discussion 181-2; quiz 183-5. https://doi.org/10.1177/0898010106295172 PMID: 17724386
Edward KL, Welch T. The extension of Colaizzi’s method of phenomenological enquiry. Contemporary Nurse. 2011;39(2):163-71. https://doi.org/10.5172/conu.2011.163 PMID: 22551429
Guba EG, Lincoln YS. Competing paradigms in qualitative research. In: Denzin NK, Lincoln YS, Eds. Qualitative research. Thousand Oaks: Sage;1994. p. 105-17.
Su Y, Wang X, Xing Y, Wang Z, Bu H, Cui X, et al. The analysis of factors affecting medication adherence in patients with myasthenia gravis: a cross-sectional study. Therapeutic Advances in Neurological Disorders. 2024;17:1-13. https://doi.org/10.1177/17562864231206877 PMID: 38654744
O’Connor L, Westerberg E, Punga AR. Myasthenia gravis and physical exercise: a novel paradigm. Frontiers in neurology. 2020; 11(675):1-12. https://doi.org/10.3389/fneur.2020.00675 PMID: 32849178
Andersen LK, Aadahl M, Vissing J. Fatigue, physical activity and associated factors in 779 patients with myasthenia gravis. Neuromuscular Disorders. 2021; 31(8):716-725. https://doi.org/10.1016/j.nmd.2021.05.007 PMID: 34303571
Surakan P, Jongudomkarn D. The family caregiver’s roles in providing care for chronically the iIl family members: a synthesis of qualitative research theses. Journal of the office of DPC 7 Khon Kaen. 2019; 26(2):83-92. Available from: https://he01.tci-thaijo.org/index.php/jdpc7kk/article/view/212973/147920 (in Thai)
Yu J, Xie L, Chen S, Fang Z, Zhu L, Zhang H, et al. Social support and medication adherence among adult myasthenia gravis patients in China: the mediating role of mental health and self-efficacy. Orphanet Journal of Rare Diseases. 2024;19(1):143. https://doi.org/10.1186/s13023-024-03145-6 PMID: 385 76038
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 The Journal of Thailand Nursing and Midwifery Council
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.